newsfilter
← Latest News
GlobeNewswire·

miRagen to Report Second Quarter 2020 Financial Results on August 5, 2020

BOULDER, Colo., July 22, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted...